The management have seemingly put a lot of effort into this meeting and emphasised the importance of it numerous times. In fact the meeting was originally slated for June but was delayed. I for one was disappointed that the primary efficacy end point was not agreed on at the meeting. The market sentiment was already negative towards Neuren and I was hoping the management was able to ace this one. Unlike Daybue sales, this is well within their control. The uncertainty has created even more negative sentiment which is evident in the sinking SP
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.31 |
Change
0.770(6.14%) |
Mkt cap ! $1.650B | |||
| Open | High | Low | Value | Volume |
| $12.96 | $14.00 | $12.91 | $19.76M | 1.453M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | $13.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.33 | 3716 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |